2013-02-03 05:21:55 - New Company Reports market report from MarketLine: "Omega Pharma NV - SWOT, Strategy and Corporate Finance Report"

Omega Pharma NV - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Omega Pharma NV required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Omega Pharma NV in the form of a SWOT analysis
* An in-depth view of the business model of Omega Pharma NV including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios

for Omega Pharma NV
* Intelligence on Omega Pharma NVnv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Omega Pharma NV, such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends


Full Report Details at
- www.fastmr.com/prod/533082_omega_pharma_nv_swot_strategy_and_cor ..


Highlights:

Omega Pharma (Omega or the 'company') is a privately-held company engaged in the development, marketing and sales of over-the-counter (OTC) pharmaceutical products. The company provides cough and cold therapies; pain relief products; vitamins, minerals, and nutritional supplements; products for gastro-intestinal disorders; skin care products; anti-allergy products; and smoking cessation therapies. It also offers anti-mosquito products, slimming products, and home diagnostics. The company primarily operates in the Europe. It is headquartered in Nazareth, Belgium, and employed 2,000 people as of December 31, 2011. Omega is a majority owned company by Couckinvest NV, and the company's shares were delisted from NYSE Euronext Brussels in February 2012. The company recorded revenues of E900.6 million ($1,254 million*) during the financial year ended December 2011 (FY2011), an increase of 5.1% over FY2010. The operating profit of the company was E80.8 million ($113 million*) in FY2011, a decrease of 24.9% over FY2010. The net profit was E36 million ($50 million*) in FY2011, a decrease of 48.3% over FY2010. *Calculated using the constant conversion rate of E1 = $1.3924 for the financial year ended December 31, 2011.
Reasons to Purchase:

* Gain understanding of Omega Pharma NV and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Omega Pharma NV as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Omega Pharma NV's business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Omega Pharma NV: Company Overview
Omega Pharma NV: Overview and Key Facts
Omega Pharma NV: Overview
Omega Pharma NV: Key Facts
Omega Pharma NV: Key Employees
Omega Pharma NV: Key Employee Biographies
Omega Pharma NV: Major Products and Services
Omega Pharma NV: Company History
Omega Pharma NV: Management Statement
Omega Pharma NV: Locations and Subsidiaries
Omega Pharma NV: Key Competitors
Omega Pharma NV: Company Analysis
Omega Pharma NV: Business Description
Omega Pharma NV: SWOT Analysis
Omega Pharma NV: SWOT Overview
Omega Pharma NV: Strengths
Omega Pharma NV: Weaknesses
Omega Pharma NV: Opportunities
Omega Pharma NV: Threats
Omega Pharma NV: Corporate Financial Deals Activity
Omega Pharma NV: Financial Deals Overview
Omega Pharma NV: Targets and Partners
Omega Pharma NV: Top Deals 2008 - 2012YTD*
Omega Pharma NV: Advisors
Omega Pharma NV: Top Legal Advisors
Omega Pharma NV: Mergers and Acquisitions
Omega Pharma NV: Partnership
Omega Pharma NV: Divestments
Omega Pharma NV: Private Equity and Ownership
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Omega Pharma NV: Key Facts
Table 2: Omega Pharma NV: Key Employees
Table 4: Omega Pharma NV: Key Competitors
Table 5: Omega Pharma NV: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Omega Pharma NV: M&A Activity by Geography (TTM*)
Table 7: Omega Pharma NV: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Table 8: Omega Pharma NV: M&A Average Deal Size - Value (US$m)
Table 9: Omega Pharma NV: Targets and Partners
Table 10: Omega Pharma NV: Top Deals 2008 - 2012YTD*
Table 11: Omega Pharma NV: Legal Advisor Ranking by Value (US$m)
Table 12: Omega Pharma NV: M&A Volume and Value Trend (2008 - YTD*2012)
Table 13: Omega Pharma NV: M&A Activity by Geography (2008 - YTD*2012)
Table 14: Omega Pharma NV: Partnership Volume and Value Trend (2008 - YTD*2012)
Table 15: Omega Pharma NV: Partnership Trend by Deal Type (2008 - YTD*2012)
Table 16: Omega Pharma NV: Divestments Volume and Value Trend (2008 - YTD*2012)
Table 17: Omega Pharma NV: Divestments by Geography (2008 - YTD*2012)
Table 18: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2008 - YTD*2012)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=533082&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.